Cornerstone Advisors (Washington)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,006	Closed	-$26K	–	1311
2018 Q3	$26K	Hold	1,006	–	–	0.02%	481
2018 Q2	$21K	Buy	1,006 +25	+3%	+$536	0.01%	496
2018 Q1	$18K	Hold	981	–	–	0.01%	526
2017 Q4	$14K	Hold	981	–	–	0.01%	532
2017 Q3	$18K	Sell	981 -282	-22%	-$4.71K	0.01%	508
2017 Q2	$21K	Hold	1,263	–	–	0.01%	486
2017 Q1	$17K	Hold	1,263	–	–	0.01%	524
2016 Q4	$19K	Hold	1,263	–	–	0.02%	507
2016 Q3	$15K	Hold	1,263	–	–	0.01%	550
2016 Q2	$14K	Buy	1,263 +254	+25%	+$2.62K	0.01%	363
2016 Q1	$9K	Buy	1,009 +375	+59%	+$4.04K	0.01%	445
2015 Q4	$9K	Hold	634	–	–	0.01%	473
2015 Q3	$10K	Buy	+634	New	+$13K	0.01%	459

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cornerstone Advisors (Washington)'s MNTA Position: Q4 2018 in Review

Cornerstone Advisors (Washington) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 1,006 shares — an estimated $26K sold.

Cornerstone Advisors (Washington) first reported a position in MNTA in Q3 2015 and held it in 13 quarters. The position peaked at $26K in Q3 2018. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

Cornerstone Advisors (Washington) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Cornerstone Advisors (Washington) sold 1,006 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $26K.
Cornerstone Advisors (Washington) first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2015 and held it in 13 quarters.
Cornerstone Advisors (Washington)'s Momenta Pharmaceuticals, Inc. position peaked at $26K in Q3 2018.
158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q4 2018, filed 16 Jan 2019.